These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

85 related items for PubMed ID: 15690388

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Modulation of systemic and renal haemodynamics by kappa-opioids in conscious lambs.
    Qi W, Smith FG.
    Exp Physiol; 2006 Sep; 91(5):877-85. PubMed ID: 16728455
    [Abstract] [Full Text] [Related]

  • 4. Kappa-opioid receptor stimulation inhibits growth of neonatal rat ventricular myocytes.
    Wang G, Wang H, Yang Y, Wong TM.
    Eur J Pharmacol; 2004 Sep 13; 498(1-3):53-8. PubMed ID: 15363975
    [Abstract] [Full Text] [Related]

  • 5. Stimulation of kappa-opioid receptor reduces isoprenaline-induced cardiac hypertrophy and fibrosis.
    Yin W, Zhang P, Huang JH, Zhang QY, Fan R, Li J, Zhou JJ, Hu YZ, Guo HT, Zhang SM, Wang YM, Kaye AD, Gu CH, Liu JC, Cheng L, Cui Q, Yi DH, Pei JM.
    Eur J Pharmacol; 2009 Apr 01; 607(1-3):135-42. PubMed ID: 19233160
    [Abstract] [Full Text] [Related]

  • 6. U50,488 increases ultrasonic vocalizations in 3-, 10-, and 18-day-old rat pups in isolation and the home cage.
    Carden SE, Davachi L, Hofer MA.
    Dev Psychobiol; 1994 Jan 01; 27(1):65-83. PubMed ID: 8112489
    [Abstract] [Full Text] [Related]

  • 7. Differential cardiovascular and renal responses produced by microinjection of the {kappa}-opioid U-50488H [(trans-3,4-dichloro-N-methyl-N-[2-(1-pyrrolidinyl)cyclohexyl]-benzene-acetamide) methane sulfonate] into subregions of the paraventricular nucleus.
    Gottlieb HB, Varner KJ, Kenigs VA, Cabral AM, Kapusta DR.
    J Pharmacol Exp Ther; 2005 Feb 01; 312(2):678-85. PubMed ID: 15381735
    [Abstract] [Full Text] [Related]

  • 8. The effect of kappa-opioid receptor agonists on tetrodotoxin-resistant sodium channels in primary sensory neurons.
    Su X, Castle NA, Antonio B, Roeloffs R, Thomas JB, Krafte DS, Chapman ML.
    Anesth Analg; 2009 Aug 01; 109(2):632-40. PubMed ID: 19608841
    [Abstract] [Full Text] [Related]

  • 9. Qualitative sex differences in kappa-opioid analgesia in mice are dependent on age.
    Sternberg WF, Ritchie J, Mogil JS.
    Neurosci Lett; 2004 Jun 10; 363(2):178-81. PubMed ID: 15172110
    [Abstract] [Full Text] [Related]

  • 10. Effects of mu-, delta- and kappa-opioid receptor agonists on methamphetamine-induced self-injurious behavior in mice.
    Mori T, Ito S, Kita T, Narita M, Suzuki T, Sawaguchi T.
    Eur J Pharmacol; 2006 Feb 17; 532(1-2):81-7. PubMed ID: 16464448
    [Abstract] [Full Text] [Related]

  • 11. Neuroprotection and functional recovery conferred by administration of kappa- and delta 1-opioid agonists in a rat model of global ischemia.
    Charron C, Messier C, Plamondon H.
    Physiol Behav; 2008 Feb 27; 93(3):502-11. PubMed ID: 18031772
    [Abstract] [Full Text] [Related]

  • 12. Activation of kappa-opioid receptors at reperfusion affords cardioprotection in both rat and mouse hearts.
    Peart JN, Gross ER, Reichelt ME, Hsu A, Headrick JP, Gross GJ.
    Basic Res Cardiol; 2008 Sep 27; 103(5):454-63. PubMed ID: 18500486
    [Abstract] [Full Text] [Related]

  • 13. Characterization of the antinociceptive effect of oxycodone in male and female rats.
    Holtman JR, Wala EP.
    Pharmacol Biochem Behav; 2006 Jan 27; 83(1):100-8. PubMed ID: 16434089
    [Abstract] [Full Text] [Related]

  • 14. Nonopioid actions of U50,488 enantiomers contribute to their peripheral cutaneous antinociceptive effects.
    Joshi SK, Gebhart GF.
    J Pharmacol Exp Ther; 2003 Jun 27; 305(3):919-24. PubMed ID: 12626643
    [Abstract] [Full Text] [Related]

  • 15. Mechanisms involved in the hypotensive effect of a kappa-opioid receptor agonist in hypertensive rats.
    Guo HT, Zhang RH, Huang LY, Li J, Liu YL, Bi H, Zhang QY, Wang YM, Sun X, Ma XL, Cheng L, Liu JC, Yu SQ, Yi DH, Pei JM.
    Arch Med Res; 2007 Oct 27; 38(7):723-9. PubMed ID: 17845890
    [Abstract] [Full Text] [Related]

  • 16. Pharmacologic evaluation of pressor and visceromotor reflex responses to bladder distension.
    Su X, Riedel ES, Leon LA, Laping NJ.
    Neurourol Urodyn; 2008 Oct 27; 27(3):249-53. PubMed ID: 17598175
    [Abstract] [Full Text] [Related]

  • 17. Effects of mu, kappa or delta opioids administered by pellet or pump on oral Salmonella infection and gastrointestinal transit.
    Feng P, Rahim RT, Cowan A, Liu-Chen LY, Peng X, Gaughan J, Meissler JJ, Adler MW, Eisenstein TK.
    Eur J Pharmacol; 2006 Mar 18; 534(1-3):250-7. PubMed ID: 16513108
    [Abstract] [Full Text] [Related]

  • 18. Delayed uncoupling is related to cardioprotection induced by kappa-agonist U-50,488H in rat heart.
    Chen BP, Mao HJ, Fan FY, Bruce IC, Xia Q.
    Scand Cardiovasc J; 2005 Dec 18; 39(6):375-82. PubMed ID: 16352491
    [Abstract] [Full Text] [Related]

  • 19. The individual and combined effects of U50,488, and flurbiprofen axetil on visceral pain in conscious rats.
    Kitamura T, Ogawa M, Yamada Y.
    Anesth Analg; 2009 Jun 18; 108(6):1964-6. PubMed ID: 19448232
    [Abstract] [Full Text] [Related]

  • 20. Anxiogenic-like effects induced by NMDA receptor activation are prevented by inhibition of neuronal nitric oxide synthase in the periaqueductal gray in mice.
    Miguel TT, Nunes-de-Souza RL.
    Brain Res; 2008 Nov 13; 1240():39-46. PubMed ID: 18793618
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.